News

Sylvie Gregoire, president of Shire HGT, the Shire business unit focused on genetic diseases, said: “The approval of Elaprase in Mexico marks a significant milestone because for the

Under the terms of the agreement, Hoya ConBio lasers will be a staple at all Hornbrook Group courses through 2009 at their Center for Advanced Clinical Education in

This trial was designed to assess the safety, tolerability and preliminary efficacy of Optisomal encapsulated Alocrest. Preliminary results show that Alocrest was generally well tolerated with acceptable and

Thallion has agreed to conduct certain additional animal studies concurrent with the US clinical study, the results of which will be submitted to the FDA in advance of

The SBIR grants awarded by the National Heart, Lung, and Blood Institute of the National Institutes of Health and the US Army will fund advancements in the Ibis

The agency concurs that a single Phase III pivotal trial should provide confirmatory evidence if the clinical and statistical benefits shown in the study are compelling. Jack Stover,

The two peptides, CGEN-856 and CGEN-857 were identified using the company’s previously announced GPCR ligand discovery platform. In an in-vivo model of cardiac remodeling, CGEN-856 and CGEN-857 were

The SameSpots software provides significant improvements in speed, objectivity and statistical power. This is said to make a radical impact on proteomics research by giving customers both the

The acquisition advances Intertek’s strategic growth in expert support services to the global pharmaceutical, medical device and drug delivery industry. BioClin will operate in Intertek’s Pharmaceutical Services Group